{"title":"癌症患者静脉血栓栓塞事件的预防","authors":"J. Fedotkina","doi":"10.21518/2307-1109-2019-1-8-24","DOIUrl":null,"url":null,"abstract":"Cancer is one of the most significant risk factors for venous thromboembolic events (VTEE). The article discusses the contemporary landscape of drug thromboprophylaxis in various groups of patients with cancer.","PeriodicalId":294380,"journal":{"name":"Atherothrombosis Journal","volume":"74 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":"{\"title\":\"PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS IN PATIENTS WITH CANCER\",\"authors\":\"J. Fedotkina\",\"doi\":\"10.21518/2307-1109-2019-1-8-24\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Cancer is one of the most significant risk factors for venous thromboembolic events (VTEE). The article discusses the contemporary landscape of drug thromboprophylaxis in various groups of patients with cancer.\",\"PeriodicalId\":294380,\"journal\":{\"name\":\"Atherothrombosis Journal\",\"volume\":\"74 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-06-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Atherothrombosis Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.21518/2307-1109-2019-1-8-24\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Atherothrombosis Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21518/2307-1109-2019-1-8-24","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS IN PATIENTS WITH CANCER
Cancer is one of the most significant risk factors for venous thromboembolic events (VTEE). The article discusses the contemporary landscape of drug thromboprophylaxis in various groups of patients with cancer.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
